Overview

Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055)

Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
Registration study
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Caspofungin
Echinocandins